[#item_full_content] The Drug Enforcement Administration (DEA) says it has no problem with reopening the record for a hearing on the Trump administration’s marijuana rescheduling proposal to include a federal watchdog report that found there are “gaps” in the government’s process for evaluating controlled substances—though it doesn’t want further briefings on the matter. Opponents of the reform,  Read More